Locations:
SearchAdvertisement
Systems genetics approach sets stage for lab testing of simvastatin and other candidate drugs
Sustained remission of seizures and neurocognitive dysfunction subsequently maintained with cannabidiol monotherapy
Modest research progress to date can still be turned into meaningful patient gains
No effect on symptom severity or disability, and low prevalence of long COVID
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel approach begins reinnervation before tumor resection, preserving a young woman’s smile
Cleveland Clinic researchers collaborate with Microsoft to create a product ready for the field
Researchers use AI tools to compare clinical events with continuous patient monitoring
Guidance on patient selection, safety surveillance, choosing among agents and more
Combining dual inhibition with anti-PD1 therapy yielded >60% rate of complete tumor regression
Insights on how stereoelectroencephalography is continuing to improve seizure localization
Advertisement
Advertisement